Abstract
Introduction a lipoprotein (LptE) in the OM LPS translocon implies that LPS transport requires functional

78
Bam and Lol pathways. A third mechanism, which is related to OM homeostasis, suggests that 79 the cell maintains a high flux of PLs to the OM to offset problems created by changes in levels of 80 other OM components [12] . Here, excess PLs can be transported back to the IM in a manner 81 dependent on the Tol-Pal complex.
82
The Tol-Pal complex is a conserved multi-protein system that forms an energy dependent Δtol-pal mutant. We selected for suppressors that rescue sensitivity to vancomycin, the large cell 114 wall-targeting antibiotic that cannot penetrate an intact and functional OM [19] . Cells have no 115 intrinsic mechanism to alter cell wall structure to give rise to resistance against vancomycin; 116 consistently, suppressor colonies appeared at a low frequency of ~1 x 10 parent Δtol-pal mutant (S1 Table) ; interestingly, all of these strains have mutations in genes 130 involved in the biosynthesis of ECA (wecB, wecC, or wecF).
131
Six strains contain mutations in wecC, which encodes a dehydrogenase enzyme in the ECA 132 synthesis pathway [18, 20] . A 6-bp in-frame insertion in wecC, termed wecC*, is common to four 133 of these strains, suggesting that this allele may be important for restoring OM barrier function in 134 the Δtol-pal mutant. To validate this, we re-constructed the wecC* mutation in the native locus 135 using a negative selection technique [21] , and confirmed that this allele alone is able to rescue 136 vancomycin sensitivity ( Fig 1A) and periplasmic leakiness in ΔtolQ, ΔtolA, and ΔtolB strains 
144
The wecC* mutation results in the insertion of two amino acids (Pro and Gly) five residues 145 away from the predicted active site Cys in the full-length protein, suggesting that WecC function 146 may be disrupted. Consistent with this, we did not detect any ECA in strains containing this 147 wecC* allele (Fig 1C) . Furthermore, we showed that deletion of wecC also partially restores 148 vancomycin resistance in tol-pal strains (Fig 1B and C) . We isolated wecB and wecF mutations 149 in two of the Class I suppressor strains (Table S1) resistance against vancomycin, similar to WT cells (Fig 2A) . Furthermore, the ∆wecC mutation 169 still partially rescued periplasmic leakiness in ∆rcsC and ∆wcaJ background strains (Fig 2B) .
170
The mechanism by which the ∆wecC mutation suppresses tol-pal phenotypes is therefore 171 independent of the Rcs phosphorelay.
172
We have observed that the ∆wecC mutation rescues vancomycin sensitivity in the ∆tolA 173 strain; however, we noted that different transductants display varying extents of suppression (S3 (Fig 3A) . The enzymes mediating the last two steps Fig 3A) . To test whether ECA loss is important, we mutated wecA, which encodes the enzyme 197 that catalyzes the first committed step in ECA biosynthesis [34] . Interestingly, we found that the Recently, it has been reported that the build-up of ECA "dead-end" intermediates in a strain 219 with defective undecaprenyl pyrophosphate synthase (UppS) [36] can lead to sequestration of 220 und-P, the common precursor for many sugar polymers in the cell envelope including 221 peptidoglycan; this gives rise to severe shape defects such as filamentation and swelling [37] .
222
Contrary to this finding, in our strains that express wild-type UppS, we did not observe major our double tol-pal wec mutants often exhibit a small colony morphology. We further showed that . We demonstrated that DAG-PP-GlcNAc species are indeed 248 present in these cells, but not in WT (Fig 5A and 5B) Fig 6) . Furthermore, we showed that the same species were specifically 254 found in the IM but not the OM of the ∆wecG mutant, as well as the ∆wecC strain ( Fig 5C) . It is 255 worth noting that DAG-PP has one extra phosphate moiety and is therefore structurally distinct OM defects in tol-pal mutants (Fig 1) (Fig 7B and S7 Fig) . The ∆wecC 274 mutation alone did not alter PL profiles in the OM. Remarkably, however, deleting wecC in the 275 ∆tolA strain not only re-established intermembrane PL distribution, but also returned the OM 276 PL/LPS ratio back to wild-type (Fig 7A and 7B) . Notably, the ∆wecC mutation had no impact on Interestingly, OMVs derived from the double mutant have a PL/LPS ratio similar to that in its OM, 288 which is essentially like WT (Fig 7B and S7 Fig) . It therefore appears that lipid dyshomeostasis in In this study, we have employed a genetic approach to gain insights into OM homeostasis in E. Mutations in ECA biosynthesis restore OM lipid homeostasis (Fig 7) , thus conferring vancomycin 307 resistance and reduced periplasmic leakiness in tol-pal strains (Figs 1 and 2 OM lipid homeostasis in tol-pal mutants (Fig 7) , but how these intermediates act to correct the 330 problem of excess PLs in the OM is not clear. We posit that the most direct mechanism(s) to 331 prevent excess PL build-up at the OM would be to modulate PL transport across the cell envelope.
332
Retrograde PL transport was not restored in the ∆tolA ∆wecC double mutant (S10 Fig); DAG-PP-GlcNAc only in the IM of the ∆wecC/∆wecG strains (Fig 5) , suggesting that such species 337 are not transported to the OM. Intriguingly, the novel DAG-PP-linked species are structurally 338 similar to PLs, which have polar headgroups linked to DAG-P (i.e. phosphatidic acid) (Fig 3A) . (Fig 4A) .
354
It is quite remarkable that our approach led to the identification of genetic interactions 
Materials and methods
366
Strains and growth conditions. All the strains used in this study are listed in S2 supplemented with 1% NaCl) and agar were prepared as previously described [48] . When Plasmid construction. Plasmids used in this study are listed in S3 Table. Desired genes were 381 amplified from MC4100 chromosomal DNA using the indicated primers (sequences in S4 382 Table) . Amplified products were digested with indicated restriction enzymes (New England and all the organic extracts pooled and dried using a Centrivap and stored at -80°C until use.
443
The lipid samples were reconstituted in chloroform:methanol (1:1, v/v) and analyzed using a calibration is performed every 5 h, using the automated calibration solution (SCIEX, Canada).
447
For lipid separation, normal phase chromatography was performed as previously described [53] .
448
For characterization of the DAG-PP species using tandem mass spectrometry, multiple collision 
